Lateral Flow Recombinase Polymerase Amplification Assays for the Detection of Human Plasmodium Species

3Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This study highlights the development of two lateral flow recombinase polymerase amplification assays for the diagnosis of human malaria. The lateral flow cassettes contained test lines that captured biotin-, 6-carboxyfluorescein, digoxigenin-, cyanine 5-, and dinitrophenyl-labeled amplicons. The overall process can be completed in 30 minutes. Recombinase polymerase amplification coupled with lateral flow had a detection limit of 1 copy/mL for Plasmodium knowlesi, Plasmodium vivax, and Plasmodium falciparum. No cross-reactivity was observed among nonhuman malaria parasites such as Plasmodium coatneyi, Plasmodium cynomolgi, Plasmodium brasilanium, Plasmodium inui, Plasmodium fragile, Toxoplasma gondii, Sarcocystis spp., Brugia spp., and 20 healthy donors. It is rapid, highly sensitive, robust, and easy to use. The result can be read without the need for special equipment and thus has the potential to serve as an effective alternative to polymerase chain reaction methods for the diagnosis of malaria.

Cite

CITATION STYLE

APA

Lai, M. Y., Hamid, M. A., Jelip, J., Mudin, R. N., & Lau, Y. L. (2023). Lateral Flow Recombinase Polymerase Amplification Assays for the Detection of Human Plasmodium Species. American Journal of Tropical Medicine and Hygiene, 108(5), 882–886. https://doi.org/10.4269/ajtmh.22-0657

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free